The Pharmacokinetic Comparison between Thiamphenicol and HP-β-CD Thiamphenicol in Rabbit
Jie Yu
Abstract
Jie Yu
Abstract
The pharmacokinetic regulations of thiamphenicol and HP-β-CD thiamphenicol were investigated by taken oral administration at a dosage of 30 mg/kg to healthy rabbits. The concentration of thiamphenicol in plasma was determined by RP-HPLC, and the data of concentration-time were analyzed by pharmacokinetic-compartment analysis soft(3P97). The data of concentration-time after oral administration of thiamphenicol and HP-β-CD thiamphenicol were all fitted to a one -compartment open model with first -order absorption. The main pharmacokinetic parameters of thiamphenicol were as follows: Lagtime(0. 05 ±0. 02)h, t1/ 2ka(0. 83 ±0. 02)h, t1/ 2ke(2.27 ±0. 31)h, T(peak) (1. 84 ±0. 12)h, C(max)(6. 98 ±0. 95)mg/ L, AUC(34. 98 ±0. 68)mg/(L·h)and F(110. 74 ±0. 02)%. The main pharmacokinetic parameters of HP-β-CD thiamphenicol were as follows: Lagtime (0. 02 ±0. 01) h, t1/2ka (0. 91 ± 0. 16) h, t1/2ke (0.86 ±0. 15) h, T(peak) (0.96 ±0. 07) h, C (max) (8.59 ±0. 55) mg/ L, AUC (43. 02 ±0. 87) mg/ (L·h), F (142.07 ±0. 02) %. The pharmacokinetic characteristics of HP-β-CD thiamphenicol in healthy rabbits manifested the rapid and complete absorption, wide distribution, rapid elimination and the high bioavailability by the oral routes.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The pharmacokinetic regulations of thiamphenicol and HP-β-CD thiamphenicol were investigated by taken oral administration at a dosage of 30 mg/kg to healthy rabbits. The concentration of thiamphenicol in plasma was determined by RP-HPLC, and the data of concentration-time were analyzed by pharmacokinetic-compartment analysis soft(3P97). The data of concentration-time after oral administration of thiamphenicol and HP-β-CD thiamphenicol were all fitted to a one -compartment open model with first -order absorption. The main pharmacokinetic parameters of thiamphenicol were as follows: Lagtime(0. 05 ±0. 02)h, t1/ 2ka(0. 83 ±0. 02)h, t1/ 2ke(2.27 ±0. 31)h, T(peak) (1. 84 ±0. 12)h, C(max)(6. 98 ±0. 95)mg/ L, AUC(34. 98 ±0. 68)mg/(L·h)and F(110. 74 ±0. 02)%. The main pharmacokinetic parameters of HP-β-CD thiamphenicol were as follows: Lagtime (0. 02 ±0. 01) h, t1/2ka (0. 91 ± 0. 16) h, t1/2ke (0.86 ±0. 15) h, T(peak) (0.96 ±0. 07) h, C (max) (8.59 ±0. 55) mg/ L, AUC (43. 02 ±0. 87) mg/ (L·h), F (142.07 ±0. 02) %. The pharmacokinetic characteristics of HP-β-CD thiamphenicol in healthy rabbits manifested the rapid and complete absorption, wide distribution, rapid elimination and the high bioavailability by the oral routes.
Key concepts: Thiamphenicol, Pharmacokinetics, Bioavailability, Absorption (acoustics), Pharmacology, Compartment (ship), Oral administration, Chemistry